| Mon, Oct 05, 2009 |
|
Closing Bell: The bull returns ahead of earnings (GE, WFC, FOLD, CIEN, VG)
BloggingStocks: Last week's sleeping bull market was brought back to a woken bull market. Despite warnings from Nouriel Roubini that things were up too much too fast, the services sector actually came in above the expansion line after 11 straight months of ... Read more
-
BloggingStocks
|
| Mon, Jun 22, 2009 |
|
|
FDA Calendar Updates: EURX, AMGN, FOLD, ONTY, MEDX
Below is a summary of updates to the BioMedReports.com FDA Calendar, which includes a database of over 200 entries. The calendar was originally created by Mike Havrilla to track companies with pending new drug, biological agent, or medical device new product decisions at the FDA. With the launch of BioMedReports.com, the FDA Calendar has expanded to include the following categories: pending new submissions to the FDA (e.g. NDA, BLA, 510k, PMA, sNDA, sBLA filings), pending complete response lette (...) [More...] |
| Thu, May 14, 2009 |
|
|
10 Extreme Trades On Pending Clinical Trial Results
As a follow-up to my recent article on nine extreme FDA trades of pending new product decisions among small and micro-cap companies, I have examined the BioMedReports.com Clinical Trial Calendar database to find companies with market caps below $250M which have pending Phase 2 or 3 clinical trial results expected before the end of 2009. Below is a sample of 10 stocks meeting this criteria from the database of 111 entries included in the BioMedReports.com Clinical Trial Calendar, which is in addi (...) [More...] |
| Tue, Dec 02, 2008 |
|
|
Don’t Give Up on Gold
If you were counting on gold to boost your returns this year, chances are you’ve been cruelly disappointed. In fact, when it comes to gold-related investments, virtually every category is down, making this one of the worst years in history… |
| Thu, Jul 31, 2008 |
|
|
Analyst Comments: EOG Resources, Charlotte Russe, VeraSun Energy, Thornburg Mortgage, Amicus Therapeutics
EOG Resources, Inc.'s (EOG) quarterly results came in better-than-expected, reflecting increased volumes and improved commodity-price realizations, partly offset by higher costs. Domestic natural gas production grew 19%, while liquids volumes rose 51% over last year. Additionally, the company raised its quarterly dividend by 12.5% to $0.135 a share. With robust growth from most of its core areas, EOG remains on track to achieve production growth of 15% this year and approximately 14% over the following two years. We maintain our Buy recommendation on EOG shares and see the stock as a core holding in the large-cap exploration and production (E&P) space. EOG is targeting 2008 production growth of approximately 15%. Driving this growth will be the company's U.S. operations, estimated to grow approximately 23% year-over-year all organic. The U.S. growth will mainly come from [More...] |
|
More Blogs
|
